Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Potential HSV-2 vaccine described by Aviron

May 5, 1997

Novel immunosuppressants from Takeda

April 29, 1997

BioChem Pharma's novel flu vaccine meets phase I trial endpoints

April 28, 1997

MedImmune's vaccine candidate prevents urinary tract infections in preclinical studies

April 28, 1997

Antex Biologics allowed patents on adhesin receptor technology and H. influenzae protein

April 28, 1997

WF-10917: new immunosuppressant from Fujisawa

April 24, 1997

North American Vaccine's acellular pertussis vaccine approved in Sweden

April 23, 1997

Connaught prepares Bordetella vaccine

April 22, 1997

Ergo Science and Massachusetts General Hospital conclude licensing agreement

April 18, 1997

MEDI-507 heads for clinical trials

April 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...